Literature DB >> 19196796

Life without thyroxine to 3,5,3'-triiodothyronine conversion: studies in mice devoid of the 5'-deiodinases.

Valerie Anne Galton1, Mark J Schneider, Ann S Clark, Donald L St Germain.   

Abstract

Considerable indirect evidence suggests that the type 2 deiodinase (D2) generates T(3) from T(4) for local use in specific tissues including pituitary, brown fat, and brain, whereas the type I deiodinase (D1) generates T(3) from T(4) in the thyroid and peripheral tissues primarily for export to plasma. From studies in deiodinase-deficient mice, the importance of the D2 for local T(3) generation has been confirmed. However, the phenotypes of these D1 knockout (KO) and D2KO mice are surprisingly mild and their serum T(3) level, general health, and reproductive capacity are unimpaired. To explore further the importance of 5'deiodination in thyroid hormone economy, we used a mouse devoid of both D1 and D2 activity. In general, the phenotype of the D1/D2KO mouse is the sum of the phenotypes of the D1KO and D2KO mice. It appears healthy and breeds well, and most surprisingly its serum T(3) level is normal. However, impairments in brain gene expression and possibly neurological function are somewhat greater than those seen in the D2KO mouse, and the serum rT(3) level is elevated 6-fold in the D1/D2KO mouse but only 2-fold in the D1KO mouse and not at all in the D2KO mouse. The data suggest that whereas D1 and D2 are not essential for the maintenance of the serum T(3) level, they do serve important roles in thyroid hormone homeostasis, the D2 being critical for local T(3) production and the D1 playing an important role in iodide conservation by serving as a scavenger enzyme in peripheral tissues and the thyroid.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196796      PMCID: PMC2689801          DOI: 10.1210/en.2008-1572

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  36 in total

Review 1.  Perspectives in the study of thyroid hormone action on brain development and function.

Authors:  Juan Bernal; Ana Guadaño-Ferraz; Beatriz Morte
Journal:  Thyroid       Date:  2003-11       Impact factor: 6.568

2.  Metabolism of triiodothyroacetic acid (TA3) in rat liver. II. Deiodination and conjugation of TA3 by rat hepatocytes and in rats in vivo.

Authors:  M Rutgers; F A Heusdens; F Bonthuis; T J Visser
Journal:  Endocrinology       Date:  1989-07       Impact factor: 4.736

3.  Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4.

Authors:  M J Schneider; S N Fiering; S E Pallud; A F Parlow; D L St Germain; V A Galton
Journal:  Mol Endocrinol       Date:  2001-12

4.  The cDNA for the type I iodothyronine 5'-deiodinase encodes an enzyme manifesting both high Km and low Km activity. Evidence that rat liver and kidney contain a single enzyme which converts thyroxine to 3,5,3'-triiodothyronine.

Authors:  J Sharifi; D L St Germain
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

5.  Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice.

Authors:  Mark J Schneider; Steven N Fiering; B Thai; Sing-yung Wu; Emily St Germain; Albert F Parlow; Donald L St Germain; Valerie Anne Galton
Journal:  Endocrinology       Date:  2005-10-13       Impact factor: 4.736

6.  Activation and inactivation of thyroid hormone by type I iodothyronine deiodinase.

Authors:  M Moreno; M J Berry; C Horst; R Thoma; F Goglia; J W Harney; P R Larsen; T J Visser
Journal:  FEBS Lett       Date:  1994-05-16       Impact factor: 4.124

7.  Direct measurement of the contributions of type I and type II 5'-deiodinases to whole body steady state 3,5,3'-triiodothyronine production from thyroxine in the rat.

Authors:  T T Nguyen; F Chapa; J J DiStefano
Journal:  Endocrinology       Date:  1998-11       Impact factor: 4.736

8.  The effects of congenital hypothyroidism using the hyt/hyt mouse on locomotor activity and learned behavior.

Authors:  A Anthony; P M Adams; S A Stein
Journal:  Horm Behav       Date:  1993-09       Impact factor: 3.587

9.  Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase.

Authors:  Lily Ng; Richard J Goodyear; Chad A Woods; Mark J Schneider; Edward Diamond; Guy P Richardson; Matthew W Kelley; Donald L St Germain; Valerie Anne Galton; Douglas Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

10.  Thyroid hormone secretion rates: response to endogenous and exogenous TSH in man during surgery.

Authors:  L Tegler; J Gillquist; R Lindvall; S Almqvist; P Roos
Journal:  Clin Endocrinol (Oxf)       Date:  1983-01       Impact factor: 3.478

View more
  67 in total

1.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 2.  Selenium, selenoproteins and the thyroid gland: interactions in health and disease.

Authors:  Lutz Schomburg
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

3.  Distinct roles of deiodinases on the phenotype of Mct8 defect: a comparison of eight different mouse genotypes.

Authors:  Xiao-Hui Liao; Caterina Di Cosmo; Alexandra M Dumitrescu; Arturo Hernandez; Jacqueline Van Sande; Donald L St Germain; Roy E Weiss; Valerie Anne Galton; Samuel Refetoff
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

4.  Triumphs of the thyroid despite lesser conversion.

Authors:  Jessica A Hall; Antonio C Bianco
Journal:  Endocrinology       Date:  2009-06       Impact factor: 4.736

Review 5.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

6.  An AOP-based alternative testing strategy to predict the impact of thyroid hormone disruption on swim bladder inflation in zebrafish.

Authors:  Evelyn Stinckens; Lucia Vergauwen; Gerald T Ankley; Ronny Blust; Veerle M Darras; Daniel L Villeneuve; Hilda Witters; David C Volz; Dries Knapen
Journal:  Aquat Toxicol       Date:  2018-04-21       Impact factor: 4.964

7.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

8.  Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC).

Authors:  Jyoti Srivastava; Chadia L Robertson; Rachel Gredler; Ayesha Siddiq; Devaraja Rajasekaran; Maaged A Akiel; Luni Emdad; Valeria Mas; Nitai D Mukhopadhyay; Paul B Fisher; Devanand Sarkar
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

9.  Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X).

Authors:  Caterina Di Cosmo; Neil McLellan; Xiao-Hui Liao; Kum Kum Khanna; Roy E Weiss; Laura Papp; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

10.  Analysis of thyroid response element activity during retinal development.

Authors:  Nathan A Billings; Mark M Emerson; Constance L Cepko
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.